By Kiku Steinfeld
Chicago, Sept. 18 – Citigroup Global Markets Holdings Inc. priced $2.76 million of 12% single observation Equity LinKed Securities due Sept. 16, 2021 linked to the common stock of Teladoc Health, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
Interest is payable monthly.
The payout at maturity will be par unless the stock finishes below the downside threshold price, 56% of the initial share price, in which case the payout will be a number of Teladoc shares equal to $1,000 divided by the initial share price or, at the issuer’s option, the cash equivalent.
Citigroup Global Markets Inc. is the underwriter.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Single observation Equity LinKed Securities
|
| Underlying stock: | Teladoc Health, Inc.
|
| Amount: | $2,757,000
|
| Maturity: | Sept. 16, 2021
|
| Coupon: | 12%, payable monthly
|
| Price: | Par
|
| Payout at maturity: | If stock finishes below downside threshold price, 5.26565 Teladoc shares; otherwise, par in cash
|
| Initial share price: | $189.91
|
| Trigger price: | $106.350; 56% of initial level
|
| Pricing date: | Sept. 11
|
| Settlement date: | Sept. 16
|
| Underwriter: | Citigroup Global Markets Inc.
|
| Fees: | 1%
|
| Cusip: | 17324X2B5
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
